Catalyst Wire Dossier Catalyst Wire Dossier

KALBITOR

ecallantide · Takeda Pharmaceuticals America, Inc.
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for KALBITOR, covering 2009-12-01 to 2020-12-28. Get the full timeline:

Most recent: FDA Approved: KALBITOR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

See pricing